Välkommen till Via TT - det enkla pressverktyget

Researchers in Sweden have created a method that now makes it possible to monitor sewage for a virus that has is believed to be linked to hepatitis outbreaks worldwide. First developed for the Covid-19 pandemic, the method can be adapted for a number of viruses, including monkey pox, offering a valuable addition to the public health toolkit.

Depressed children and teenagers have an increased risk of suffering from premature death and a wide range of illnesses later in life. That is according to a large observational study by researchers at Karolinska Institutet in Sweden. The findings highlight the need to look for other potential diseases following childhood or adolescent depression. Other psychiatric conditions, such as anxiety and substance misuse, can explain part of the association. The study is published in the journal JAMA Psychiatry.

Among adults with chronic viral hepatitis at high risk of liver cancer, those who took low-dose aspirin long-term were less likely to develop liver cancer or to die from liver-related causes. The findings come from a study published in the New England Journal of Medicine and conducted by a team led by investigators at Karolinska Institutet and Örebro University Hospital in Sweden and Massachusetts General Hospital in the U.S.

Fat-soluble statins can prevent liver cancer and reduce mortality in patients with chronic viral hepatitis. These are findings from a study conducted by researchers at Karolinska Institutet in Sweden, among others. The study is published in Annals of Internal Medicine.

Fettlösliga statiner kan förebygga levercancer och minskar dödligheten hos patienter med virushepatit. Det visar en studie av forskare vid bland annat Karolinska Institutet som publiceras i Annals of Internal Medicine.

[PRESS RELEASE 2018-06-11] Changes to the immune system remain many years after a hepatitis C infection heals, a new study by researchers at Karolinska Institutet and Hannover Medical School shows. The findings, presented in Nature Communications, increases understanding about chronic infection and the way it regulates and impacts composition of the immune system.

Förändringar i immunförsvaret finns kvar flera år efter att en infektion med hepatit C läkt ut. Det visar forskare vid Karolinska Institutet och Hannover Medical School i en ny studie som publiceras i den vetenskapliga tidskriften Nature Communications. Resultaten ökar förståelsen för hur immunsystemets sammansättning regleras och påverkas vid kronisk infektion.

[PRESS INVITATION, 18 May 2015] The new hepatitis C drugs represent a genuine breakthrough in pharmaceutical research, and would not have been possible without the work done on the virus by Charles Rice at Rockefeller University. Dr Rice is now coming to Sweden to speak about hepatitis C for the annual Nicholson lecture, where an introduction will be given by one of Sweden's best-known hepatitis C patients, Professor Hans Rosling.

De nya läkemedlen mot hepatit C representerar verkliga genombrott inom läkemedelsforskningen. De hade inte varit möjliga utan den forskning som Charles Rice vid Rockefeller University bedrivit kring viruset. Nu kommer han till Sverige för att tala om hepatit C under ett möte då vi också får träffa en av Sveriges mest kända hepatit C-patienter, professor Hans Rosling.